Iridex (IRIX) Non-Current Deferred Tax Liability (2022)
Iridex (IRIX) posted quarterly Non-Current Deferred Tax Liability of $104000.0 for Q4 2022.
Iridex (IRIX) Non-Current Deferred Tax Liability (2022) Analysis & Trends
Iridex's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $104000.0 for Q4 2022.
- In Q4 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $104000.0; the TTM figure through Dec 2022 stood at $104000.0 (changed N/A YoY), while the FY2022 annual figure was $104000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2022 stood at $104000.0.
- The five-year high for Non-Current Deferred Tax Liability was $104000.0 in Q4 2022, with the low at $104000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 104,000.00 |
| Dec 31, 2022 | 104,000.00 |